A study of switching from Entecavir to Tenofovir Disoproxil Fumarate in subjects with chronic hepatitis B

Trial Identifier: 205883
Sponsor: GlaxoSmithKline
Start Date: October 2017
Primary Completion Date: December 2018
Study Completion Date: November 2019
Condition: Hepatitis B

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Japan Aichi, Japan, 467-8602
Japan Chiba, Japan, 270-1694
Japan Ehime, Japan, 790-0024
Japan Ehime, Japan, 790-8524
Japan Fukuoka, Japan, 830-0011
Japan Fukuoka, Japan, 802-0077
Japan Fukuoka, Japan, 810-8539
Japan Hiroshima, Japan, 737-0023
Japan Hokkaido, Japan, 060-0033
Japan Hokkaido, Japan, 080-0024
Japan Kanagawa, Japan, 216-8511
Japan Kanagawa, Japan, 213-8587
Japan Kumamoto, Japan, 862-8655
Japan Nagasaki, Japan, 856-8562
Japan Osaka, Japan, 545-8586
Japan Tokyo, Japan, 180-8610
Japan Tokyo, Japan, 105-8470
Japan Tottori, Japan, 683-0002